<p>安大略省多伦多 --（Newsfile Corp. -2026 年 3 月 4 日）- Safe Supply Streaming Co Ltd.（CSE: SPLY）（OTCQB: SSPLF）（FSE: QM4）（&#34; <strong>Safe Supply</strong>&#34; 或 &#34; <strong>公司</strong>&#34;），作为健康、安全和快速响应技术的先驱，今天提供了关于其 NIRLAB SA（&#34; <strong>NIRLAB</strong>&#34;）试点项目的更新，确认 NIRLAB NIRLIGHT 光谱药物分析设备目前已与政府利益相关者部署，并正在积极进行现场测试。公司还报告向一个原住民团体出售了另外两台 NIRLAB NIRLIGHT 设备，反映出在原住民社区中的持续采用。</p>
<p>政府利益相关者的积极现场评估代表了 Safe Supply 在追求 NIRLAB 平台的机构采用战略中的重要一步。这些部署是在与联邦、省、市和原住民政府机构进行的一系列现场演示之后进行的，其中一些现在已进入现场评估阶段。</p>
<p><strong>政府现场试点：从演示到积极评估</strong></p>
<p>在过去几个月中，Safe Supply 进行了系统的政府利益相关者参与计划，包括与多个司法管辖区和公共健康与安全责任领域的机构进行 NIRLAB NIRLIGHT 设备的现场演示。这种参与已超越了初步讨论：许多机构现在已收到设备并正在进行自己的现场评估。</p>
<p>试点项目围绕三个核心目标构建：</p>
<ul>
<li>验证 NIRLIGHT 系统在代表真实政府使用案例的一系列操作环境中的性能</li>
<li>生成现场级证据，以支持参与机构的正式采购评估和决策</li>
<li>确立 Safe Supply 作为参与前线药物响应和公共安全的加拿大政府机构的可信赖技术合作伙伴</li>
</ul>
<p><strong>持续采用：向原住民团体出售两台额外设备</strong></p>
<p>除了试点项目更新外，Safe Supply 还报告向加拿大的一个原住民团体出售了另外两台 NIRLAB NIRLIGHT 设备。这些交易增加了公司在原住民社区内设备部署的不断增长的基础，反映出在识别现场药物分析作为实用社区安全工具的原住民合作伙伴中持续的采用模式。</p>
<p>对于那些地理偏远和接入差距使实验室测试不切实际的社区，NIRLIGHT 系统的现场准备设计满足了一个众所周知的需求。该设备提供近乎即时的结果而不破坏样本，支持前线工作人员实时做出更明智的决策。关键功能包括：</p>
<ul>
<li>通过 iOS/Android 移动应用进行快速、非破坏性的 NIR 光谱分析，结果在几秒钟内得出</li>
<li>每个样本识别和相对定量最多三种物质，包括活性化合物和常见切割剂</li>
<li>便携式、由电池供电的设计，适用于偏远和现场环境，支持 NIRWeb 和 NIRCloud 数据管理</li>
<li>与现有健康和安全工作流程兼容，包括假定的基于条带的测试</li>
</ul>
<p>&#34;我们的政府试点项目向积极现场评估的推进是 Safe Supply 的一个关键运营里程碑，&#34; <strong>Safe Supply 首席执行官 Geoff Benic</strong> 表示。&#34;将设备交到政府利益相关者手中进行现实世界测试是机构采用的开始。这是一个需要时间的过程，并且在每一步都需要信誉，我们致力于赢得这一点。向原住民团体的额外设备销售进一步表明，在社区层面，这项技术的案例仍然通过其所提供的结果得以建立。&#34;</p>
<p>&#34;在联邦警务工作了 34 年，我见证了当前线团队没有及时、可靠的情报来了解药物供应中实际情况时会发生什么，&#34; <strong>退役 RCMP 副专员 Raf Souccar，Safe Supply 董事会主席</strong> 表示。&#34;像 NIRLIGHT 这样的工具改变了这一局面。我们现在看到的社区首先采用，然后是政府现场评估，正是可信的公共安全技术在加拿大获得 traction 的方式。根据我的经验，我们正在朝着正确的方向前进。&#34;</p>
<p><strong>关于 Safe Supply Streaming Co Ltd.</strong></p>
<p>Safe Supply Streaming Co Ltd.（CSE: SPLY）（OTCQB: SSPLF）（FSE: QM4）是一家公开交易的公司，致力于构建和支持医疗保健、健康和新兴技术的创新。通过收购、合作伙伴关系和增长资本，公司组建了一个多元化的投资组合，利用数据、科学和数字平台来改善大规模的获取和结果。Safe Supply 在公共健康和技术的交汇处运营，支持基于证据的解决方案以应对紧迫的社会需求。</p>
<p>欲了解更多信息，请访问 www.safesupply.com</p>
<p>代表 Safe Supply Streaming Co Ltd.董事会</p>
<p><strong>加拿大证券交易所对本新闻稿的充分性或准确性不承担任何责任，也未批准或否决其内容。</strong></p>
<p><strong>关于前瞻性声明的警示说明</strong></p>
<p>本新闻稿包含某些可能构成适用的加拿大证券法下的 “前瞻性信息” 或 “前瞻性声明” 的陈述。前瞻性声明包括但不限于关于：政府试点项目的预期进展和结果；政府机构的潜在采购考虑；NIRLAB 设备在土著社区中的持续采用；公司产品组合的互补性；以及公司的整体商业化战略。前瞻性声明反映了管理层当前的期望和假设，并受到已知和未知的风险和不确定性的影响，这些因素可能导致实际结果与预期有重大差异，包括但不限于：政府采购优先事项的变化；监管发展；维持分销独占性的能力；市场采用率；一般经济状况；以及公司实现其运营目标的能力。</p>
<p>尽管公司认为此处反映的期望是合理的，但读者不应对前瞻性声明过于依赖。公司不承担更新或修订任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，除非适用法律要求。</p>
<p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/286213</p>
<p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/286213/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/286213/375"/></p>

SUPP

SUPL

<p>安全供应流媒体有限公司已确认其 NIRLAB NIRLIGHT 药物分析设备正在积极部署，并由政府相关方进行现场评估。该试点项目旨在验证系统性能，为采购决策提供证据，并确立安全供应作为可信的技术合作伙伴。此外，公司还向一个原住民团体出售了另外两台设备，突显了在原住民社区中的持续采用。首席执行官 Geoff Benic 强调了现实世界测试对机构采用的重要性，而前皇家骑警副专员 Raf Souccar 则指出在药物供应管理中及时情报的关键需求</p>

<p>Toronto, Ontario--(Newsfile Corp. - March 4, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) (&#34; <strong>Safe Supply</strong>&#34; or the &#34; <strong>Company</strong>&#34;), a pioneer in health, safety, and rapid response technologies, today provided an update on its NIRLAB SA (&#34; <strong>NIRLAB</strong>&#34;) pilot program, confirming that NIRLAB NIRLIGHT spectroscopy drug analysis devices are currently deployed with government stakeholders and are being actively tested in the field. The Company is also reporting the sale of two additional NIRLAB NIRLIGHT devices to a First Nations group, reflecting ongoing adoption across Indigenous communities.</p>
<div class="lb-trans"><p>安大略省多伦多 --（Newsfile Corp. -2026 年 3 月 4 日）- Safe Supply Streaming Co Ltd.（CSE: SPLY）（OTCQB: SSPLF）（FSE: QM4）（&#34; <strong>Safe Supply</strong>&#34; 或 &#34; <strong>公司</strong>&#34;），作为健康、安全和快速响应技术的先驱，今天提供了关于其 NIRLAB SA（&#34; <strong>NIRLAB</strong>&#34;）试点项目的更新，确认 NIRLAB NIRLIGHT 光谱药物分析设备目前已与政府利益相关者部署，并正在积极进行现场测试。公司还报告向一个原住民团体出售了另外两台 NIRLAB NIRLIGHT 设备，反映出在原住民社区中的持续采用。</p>
</div><p>The active field evaluation by government stakeholders represents a meaningful step in Safe Supply's strategy to pursue institutional adoption of the NIRLAB platform. These deployments follow a series of live demonstrations conducted with federal, provincial, municipal, and Indigenous government agencies, several of which have now progressed to in-field evaluation.</p>
<div class="lb-trans"><p>政府利益相关者的积极现场评估代表了 Safe Supply 在追求 NIRLAB 平台的机构采用战略中的重要一步。这些部署是在与联邦、省、市和原住民政府机构进行的一系列现场演示之后进行的，其中一些现在已进入现场评估阶段。</p>
</div><p><strong>Government Field Pilot: From Demonstration to Active Evaluation</strong></p>
<div class="lb-trans"><p><strong>政府现场试点：从演示到积极评估</strong></p>
</div><p>Over the past few months, Safe Supply has conducted a systematic program of government stakeholder engagement, including live demonstrations of the NIRLAB NIRLIGHT device with agencies operating across multiple jurisdictions and areas of public health and safety responsibility. This engagement has progressed beyond introductory discussions: a number of those agencies have now received devices and are conducting their own field-based evaluations.</p>
<div class="lb-trans"><p>在过去几个月中，Safe Supply 进行了系统的政府利益相关者参与计划，包括与多个司法管辖区和公共健康与安全责任领域的机构进行 NIRLAB NIRLIGHT 设备的现场演示。这种参与已超越了初步讨论：许多机构现在已收到设备并正在进行自己的现场评估。</p>
</div><p>The pilot program is structured around three core objectives:</p>
<div class="lb-trans"><p>试点项目围绕三个核心目标构建：</p>
</div><ul>
<li>To validate NIRLIGHT system performance across a range of operational environments representative of real-world government use cases</li>
<li>To generate field-level evidence that can support formal procurement evaluation and decision-making within participating agencies</li>
<li>To establish Safe Supply as a credible, reliable technology partner for Canadian government bodies engaged in frontline drug response and public safety</li>
</ul>
<div class="lb-trans"><ul>
<li>验证 NIRLIGHT 系统在代表真实政府使用案例的一系列操作环境中的性能</li>
<li>生成现场级证据，以支持参与机构的正式采购评估和决策</li>
<li>确立 Safe Supply 作为参与前线药物响应和公共安全的加拿大政府机构的可信赖技术合作伙伴</li>
</ul>
</div><p><strong>Continued Adoption: Two Additional Device Sales to First Nations Group</strong></p>
<div class="lb-trans"><p><strong>持续采用：向原住民团体出售两台额外设备</strong></p>
</div><p>In addition to the pilot program update, Safe Supply reports the sale of two additional NIRLAB NIRLIGHT devices to a First Nations group in Canada. The transactions add to the Company's growing base of device deployments within Indigenous communities under its exclusive Canadian distribution agreement with NIRLAB, and reflect a consistent pattern of adoption among First Nations partners who have identified on-site drug analysis as a practical community safety tool.</p>
<div class="lb-trans"><p>除了试点项目更新外，Safe Supply 还报告向加拿大的一个原住民团体出售了另外两台 NIRLAB NIRLIGHT 设备。这些交易增加了公司在原住民社区内设备部署的不断增长的基础，反映出在识别现场药物分析作为实用社区安全工具的原住民合作伙伴中持续的采用模式。</p>
</div><p>For communities where geographic remoteness and access gaps make laboratory-based testing impractical, the NIRLIGHT system's field-ready design addresses a well-documented need. The device delivers near-instantaneous results without destroying the sample, supporting frontline workers in making better-informed decisions in real time. Key capabilities include:</p>
<div class="lb-trans"><p>对于那些地理偏远和接入差距使实验室测试不切实际的社区，NIRLIGHT 系统的现场准备设计满足了一个众所周知的需求。该设备提供近乎即时的结果而不破坏样本，支持前线工作人员实时做出更明智的决策。关键功能包括：</p>
</div><ul>
<li>Rapid, non-destructive NIR spectroscopy with results in seconds via iOS/Android mobile app</li>
<li>Identification and relative quantification of up to three substances per sample, including active compounds and common cutting agents</li>
<li>Portable, battery-powered design built for remote and field settings, with NIRWeb and NIRCloud data management support</li>
<li>Compatibility with existing health and safety workflows, including presumptive strip-based testing</li>
</ul>
<div class="lb-trans"><ul>
<li>通过 iOS/Android 移动应用进行快速、非破坏性的 NIR 光谱分析，结果在几秒钟内得出</li>
<li>每个样本识别和相对定量最多三种物质，包括活性化合物和常见切割剂</li>
<li>便携式、由电池供电的设计，适用于偏远和现场环境，支持 NIRWeb 和 NIRCloud 数据管理</li>
<li>与现有健康和安全工作流程兼容，包括假定的基于条带的测试</li>
</ul>
</div><p>&#34;The advancement of our government pilot program into active field evaluation is a key operational milestone for Safe Supply,&#34; said <strong>Geoff Benic, Chief Executive Officer of Safe Supply.</strong> &#34;Getting devices into the hands of government stakeholders for real-world testing is how institutional adoption begins. It is a process that takes time and requires credibility at every step, and we are committed to earning that. The additional device sales to a First Nations group are a further indication that, at the community level, the case for this technology continues to be made by the results it delivers.&#34;</p>
<div class="lb-trans"><p>&#34;我们的政府试点项目向积极现场评估的推进是 Safe Supply 的一个关键运营里程碑，&#34; <strong>Safe Supply 首席执行官 Geoff Benic</strong> 表示。&#34;将设备交到政府利益相关者手中进行现实世界测试是机构采用的开始。这是一个需要时间的过程，并且在每一步都需要信誉，我们致力于赢得这一点。向原住民团体的额外设备销售进一步表明，在社区层面，这项技术的案例仍然通过其所提供的结果得以建立。&#34;</p>
</div><p>&#34;After 34 years in federal policing, I've seen what happens when frontline teams don't have timely, reliable intelligence on what's actually in the drug supply,&#34; said <strong>Raf Souccar, RCMP Deputy Commissioner (Ret'd), Chairman of the Board of Safe Supply.</strong> &#34;Tools like NIRLIGHT change that equation. What we're seeing now with community adoption first, followed by government field evaluation, is exactly how credible public safety technology gains traction in Canada. From my experience, we are moving in the right direction.&#34;</p>
<div class="lb-trans"><p>&#34;在联邦警务工作了 34 年，我见证了当前线团队没有及时、可靠的情报来了解药物供应中实际情况时会发生什么，&#34; <strong>退役 RCMP 副专员 Raf Souccar，Safe Supply 董事会主席</strong> 表示。&#34;像 NIRLIGHT 这样的工具改变了这一局面。我们现在看到的社区首先采用，然后是政府现场评估，正是可信的公共安全技术在加拿大获得 traction 的方式。根据我的经验，我们正在朝着正确的方向前进。&#34;</p>
</div><p><strong>About Safe Supply Streaming Co Ltd.</strong></p>
<div class="lb-trans"><p><strong>关于 Safe Supply Streaming Co Ltd.</strong></p>
</div><p>Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) is a publicly traded company building and backing innovations in healthcare, wellness, and emerging technologies. Through acquisitions, partnerships, and growth capital, the Company assembles a diversified portfolio that leverages data, science, and digital platforms to improve access and outcomes at scale. Operating at the intersection of public health and technology, Safe Supply supports evidence-informed solutions to urgent societal needs.</p>
<div class="lb-trans"><p>Safe Supply Streaming Co Ltd.（CSE: SPLY）（OTCQB: SSPLF）（FSE: QM4）是一家公开交易的公司，致力于构建和支持医疗保健、健康和新兴技术的创新。通过收购、合作伙伴关系和增长资本，公司组建了一个多元化的投资组合，利用数据、科学和数字平台来改善大规模的获取和结果。Safe Supply 在公共健康和技术的交汇处运营，支持基于证据的解决方案以应对紧迫的社会需求。</p>
</div><p>For more information, please visit www.safesupply.com</p>
<div class="lb-trans"><p>欲了解更多信息，请访问 www.safesupply.com</p>
</div><p>On behalf of the Board of Directors of Safe Supply Streaming Co Ltd.</p>
<div class="lb-trans"><p>代表 Safe Supply Streaming Co Ltd.董事会</p>
</div><p><strong>The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this news release and has neither approved nor disapproved its contents.</strong></p>
<div class="lb-trans"><p><strong>加拿大证券交易所对本新闻稿的充分性或准确性不承担任何责任，也未批准或否决其内容。</strong></p>
</div><p><strong>Cautionary Note Regarding Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>关于前瞻性声明的警示说明</strong></p>
</div><p>This press release contains certain statements that may constitute &#34;forward-looking information&#34; or &#34;forward-looking statements&#34; within the meaning of applicable Canadian securities laws. Forward-looking statements include, but are not limited to, statements regarding: the anticipated progression and outcomes of the government pilot program; potential procurement consideration by government agencies; continued adoption of NIRLAB devices within Indigenous communities; the complementary nature of the Company's product portfolio; and the Company's overall commercialization strategy. Forward-looking statements reflect management's current expectations and assumptions and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including but not limited to: changes in government procurement priorities; regulatory developments; the ability to maintain distribution exclusivity; market adoption rates; general economic conditions; and the Company's ability to execute on its operational objectives.</p>
<div class="lb-trans"><p>本新闻稿包含某些可能构成适用的加拿大证券法下的 “前瞻性信息” 或 “前瞻性声明” 的陈述。前瞻性声明包括但不限于关于：政府试点项目的预期进展和结果；政府机构的潜在采购考虑；NIRLAB 设备在土著社区中的持续采用；公司产品组合的互补性；以及公司的整体商业化战略。前瞻性声明反映了管理层当前的期望和假设，并受到已知和未知的风险和不确定性的影响，这些因素可能导致实际结果与预期有重大差异，包括但不限于：政府采购优先事项的变化；监管发展；维持分销独占性的能力；市场采用率；一般经济状况；以及公司实现其运营目标的能力。</p>
</div><p>Although the Company believes that the expectations reflected herein are reasonable, readers should not place undue reliance on forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.</p>
<div class="lb-trans"><p>尽管公司认为此处反映的期望是合理的，但读者不应对前瞻性声明过于依赖。公司不承担更新或修订任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，除非适用法律要求。</p>
</div><p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286213</p>
<div class="lb-trans"><p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/286213</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/286213/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/286213/375"/></p>

Safe Supply 确认 NIRLAB 药物分析设备已被积极部署，并正在接受政府利益相关者的现场评估 | SSPLF 股票新闻